SELLAS Life Sciences Group's chart data is dated 2026-10-09. Recorded technical signals: MACD bullish cross. There are 5 published signal records.
SELLAS Life Sciences Group last closed at $11.65 (+3.46%) on 2026-10-09. Signals today: MACD bullish cross. Listed on Nasdaq. Trailing 12 months PER is -67.9×. Its overall grade ranks 11 of 736 stocks in Healthcare.
About this company
SELLAS Life Sciences Group last closed at $11.65 (+3.46%) on 2026-10-09. Signals today: MACD bullish cross. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall A+ · 11/736
Valuation grade A+
Related stocks
- MerckCompetitor
면역항암제·암 치료제 개발 분야에서 경쟁 관계
- Bristol Myers SquibbCompetitor
종양학 파이프라인과 면역항암제 분야의 경쟁사
- AmgenCompetitor
항암·면역치료 신약 개발에서 경쟁
ETFs holding this stock
Virtus LifeSci Biotech Clinical Trials ETF · Etho Climate Leadership US ETF · iShares Micro-Cap ETF
Details →About SELLAS Life Sciences Group
- What technical signals does SELLAS Life Sciences Group (SLS) have?
- SELLAS Life Sciences Group current technical signals: MACD bullish cross.
- Is SELLAS Life Sciences Group a cup-and-handle pattern?
- No. SELLAS Life Sciences Group has no valid Cup signal right now.
- What published figures are available for SELLAS Life Sciences Group?
- Market cap: $1.66B. Trailing 12 months PER: -67.9×. Latest quarter PBR: 16.01×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Turn what you saw on this name into a strategy
Ask Q about SELLAS Life Sciences Group, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.